Go Pro
→ Bezos… DOOMED (From Paradigm Press) (Ad)tc pixel Free CDTTW Stock Alerts

Conduit Pharmaceuticals (CDTTW) Competitors

$0.0092 0.00 (-13.27%)
Closing price 09:19 AM Eastern
Extended Trading
$0.01 0.00 (0.00%)
As of 09:19 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare

CDTTW vs. SXTPW, BFRIW, CINGW, CLVR, and CMRAW

Should you buy Conduit Pharmaceuticals stock or one of its competitors? Conduit Pharmaceuticals's main competitors and comparable companies include 60 Degrees Pharmaceuticals (SXTPW), Biofrontera (BFRIW), Cingulate (CINGW), Clever Leaves (CLVR), and Comera Life Sciences (CMRAW). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "pharmaceuticals" industry.

How does Conduit Pharmaceuticals compare to 60 Degrees Pharmaceuticals?

Conduit Pharmaceuticals (NASDAQ:CDTTW) and 60 Degrees Pharmaceuticals (NASDAQ:SXTPW) are both healthcare companies, but which is the better business? We will compare the two companies based on the strength of their earnings, institutional ownership, risk, dividends, valuation, profitability, media sentiment and analyst recommendations.

Company Net Margins Return on Equity Return on Assets
Conduit PharmaceuticalsN/A N/A N/A
60 Degrees Pharmaceuticals N/A N/A N/A

In the previous week, 60 Degrees Pharmaceuticals had 1 more articles in the media than Conduit Pharmaceuticals. MarketBeat recorded 1 mentions for 60 Degrees Pharmaceuticals and 0 mentions for Conduit Pharmaceuticals. 60 Degrees Pharmaceuticals' average media sentiment score of 1.99 beat Conduit Pharmaceuticals' score of 0.00 indicating that 60 Degrees Pharmaceuticals is being referred to more favorably in the news media.

Company Overall Sentiment
Conduit Pharmaceuticals Neutral
60 Degrees Pharmaceuticals Very Positive

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Conduit PharmaceuticalsN/AN/AN/AN/AN/A
60 Degrees Pharmaceuticals$1.11MN/AN/AN/AN/A

Summary

60 Degrees Pharmaceuticals beats Conduit Pharmaceuticals on 3 of the 3 factors compared between the two stocks.

How does Conduit Pharmaceuticals compare to Biofrontera?

Biofrontera (NASDAQ:BFRIW) and Conduit Pharmaceuticals (NASDAQ:CDTTW) are both healthcare companies, but which is the better business? We will contrast the two companies based on the strength of their earnings, risk, analyst recommendations, dividends, institutional ownership, valuation, profitability and media sentiment.

In the previous week, Biofrontera's average media sentiment score of 0.00 equaled Conduit Pharmaceuticals'average media sentiment score.

Company Overall Sentiment
Biofrontera Neutral
Conduit Pharmaceuticals Neutral

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Biofrontera$46.18MN/AN/AN/AN/A
Conduit PharmaceuticalsN/AN/AN/AN/AN/A

Company Net Margins Return on Equity Return on Assets
BiofronteraN/A N/A N/A
Conduit Pharmaceuticals N/A N/A N/A

Summary

Biofrontera beats Conduit Pharmaceuticals on 1 of the 1 factors compared between the two stocks.

How does Conduit Pharmaceuticals compare to Cingulate?

Conduit Pharmaceuticals (NASDAQ:CDTTW) and Cingulate (NASDAQ:CINGW) are both healthcare companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, analyst recommendations, profitability, risk, dividends, earnings, media sentiment and valuation.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Conduit PharmaceuticalsN/AN/AN/AN/AN/A
CingulateN/AN/AN/AN/AN/A

In the previous week, Conduit Pharmaceuticals' average media sentiment score of 0.00 equaled Cingulate'saverage media sentiment score.

Company Overall Sentiment
Conduit Pharmaceuticals Neutral
Cingulate Neutral

Company Net Margins Return on Equity Return on Assets
Conduit PharmaceuticalsN/A N/A N/A
Cingulate N/A N/A N/A

Summary

Conduit Pharmaceuticals and Cingulate tied by winning 0 of the 0 factors compared between the two stocks.

How does Conduit Pharmaceuticals compare to Clever Leaves?

Clever Leaves (NASDAQ:CLVR) and Conduit Pharmaceuticals (NASDAQ:CDTTW) are both healthcare companies, but which is the superior investment? We will contrast the two businesses based on the strength of their earnings, profitability, analyst recommendations, valuation, institutional ownership, media sentiment, dividends and risk.

6.9% of Clever Leaves shares are held by institutional investors. 8.2% of Clever Leaves shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Company Net Margins Return on Equity Return on Assets
Clever LeavesN/A N/A N/A
Conduit Pharmaceuticals N/A N/A N/A

Conduit Pharmaceuticals has lower revenue, but higher earnings than Clever Leaves.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Clever Leaves$17.42M0.00-$17.90M-$9.66N/A
Conduit PharmaceuticalsN/AN/AN/AN/AN/A

In the previous week, Clever Leaves' average media sentiment score of 0.00 equaled Conduit Pharmaceuticals'average media sentiment score.

Company Overall Sentiment
Clever Leaves Neutral
Conduit Pharmaceuticals Neutral

Summary

Clever Leaves beats Conduit Pharmaceuticals on 3 of the 3 factors compared between the two stocks.

How does Conduit Pharmaceuticals compare to Comera Life Sciences?

Conduit Pharmaceuticals (NASDAQ:CDTTW) and Comera Life Sciences (NASDAQ:CMRAW) are both healthcare companies, but which is the superior business? We will compare the two businesses based on the strength of their valuation, institutional ownership, dividends, risk, earnings, media sentiment, analyst recommendations and profitability.

Company Net Margins Return on Equity Return on Assets
Conduit PharmaceuticalsN/A N/A N/A
Comera Life Sciences N/A N/A N/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Conduit PharmaceuticalsN/AN/AN/AN/AN/A
Comera Life Sciences$1.00MN/AN/AN/AN/A

In the previous week, Conduit Pharmaceuticals' average media sentiment score of 0.00 equaled Comera Life Sciences'average media sentiment score.

Company Overall Sentiment
Conduit Pharmaceuticals Neutral
Comera Life Sciences Neutral

Summary

Comera Life Sciences beats Conduit Pharmaceuticals on 1 of the 1 factors compared between the two stocks.

Get Conduit Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for CDTTW and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CDTTW vs. The Competition

Export
MetricConduit PharmaceuticalsPharmaceuticals IndustryHealthcare SectorNASDAQ Exchange
Market CapN/A$12.18B$7.20B$12.86B
Dividend YieldN/A2.59%2.53%8.57%
P/E RatioN/A787.20272.9325.37
Price / SalesN/A759.68617.6998.61
Price / CashN/A94.8077.8252.27
Price / BookN/A12.4012.866.16
Net IncomeN/A$2.82B$3.47B$349.63M
7 Day PerformanceN/A3.87%1.01%-0.16%
1 Month PerformanceN/A6.79%5.69%0.73%
1 Year PerformanceN/A10.53%25.55%15.35%

Conduit Pharmaceuticals Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
CDTTW
Conduit Pharmaceuticals
N/A$0.01
-13.3%		N/A-27.8%$0.00N/AN/A7
SXTPW
60 Degrees Pharmaceuticals
N/A$0.03
flat		N/A-62.0%$0.00$1.11MN/A2
BFRIW
Biofrontera
N/A$0.02
-10.0%		N/A-83.7%$0.00$46.18MN/A70
CINGW
Cingulate
N/A$0.01
+1.1%		N/A-84.3%$0.00N/AN/A20
CLVR
Clever Leaves
N/A$0.00
flat		N/AN/A$0.00$17.42MN/A560

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (NASDAQ:CDTTW) was last updated on 9/4/2026 by MarketBeat.com Staff.
From Our Partners
How Long Does $2.5M Last in Retirement?
Having $2.5 million saved puts you ahead of most Americans, but how long it lasts depends on the decisions you...
SmartAsset | Sponsoredtc pixel
Three companies about to leapfrog Nvidia [And transform the entire industry]
AI data centers have a power problem nobody likes to talk about. A single rack of computers can now use more e...
Eagle Publishing | Sponsoredtc pixel
Major Buy Alert Issued for September 30th
Keith Kaplan has invested $17 million into his own AI research tools, building a platform now used by 180,000 ...
TradeSmith | Sponsoredtc pixel
Man who Predicted Trump 2016 Win: “Prepare for Mid-Term Meltdown”
In 2016, major election models gave Hillary Clinton a 99% chance of winning - but former CIA and Pentagon advi...
Paradigm Press | Sponsoredtc pixel
Earth's biggest energy source: near Grand Canyon
The largest energy source on Earth contains 50,000 times every oil and gas reserve on the planet combined - an...
Behind the Markets | Sponsoredtc pixel
Anthropic’s confidential SEC filing — and the public ticker that holds it
Anthropic filed confidentially for an IPO, and its annualized revenue run rate reportedly surged to $65 billio...
The Oxford Club | Sponsoredtc pixel
Near retirement? Buy this stock
On August 9, the Wall Street Journal profiled a unique AI strategy used by three companies. Whitney Tilson of ...
Stansberry Research | Sponsoredtc pixel
Trump’s “new Petrodollar” exposed
Trump has reportedly secured control over 65 billion barrels across 17 Venezuelan oil fields, more than the en...
Porter & Company | Sponsoredtc pixel